Peter Hölig

672 total citations
10 papers, 565 citations indexed

About

Peter Hölig is a scholar working on Pharmaceutical Science, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Peter Hölig has authored 10 papers receiving a total of 565 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pharmaceutical Science, 4 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Peter Hölig's work include Drug Solubulity and Delivery Systems (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Peter Hölig is often cited by papers focused on Drug Solubulity and Delivery Systems (5 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Glycosylation and Glycoproteins Research (2 papers). Peter Hölig collaborates with scholars based in Germany, Denmark and Norway. Peter Hölig's co-authors include Martin Brandl, Gert Fricker, Karin M. Rosenblatt, Ulrich Westedt, Kerstin J. Frank, Jörg Rosenberg, Roland E. Kontermann, Rolf Müller, Sven Falkenstein Hoffmann and Ingunn Tho and has published in prestigious journals such as Biochimica et Biophysica Acta (BBA) - Biomembranes, International Journal of Pharmaceutics and Journal of Pharmaceutical Sciences.

In The Last Decade

Peter Hölig

10 papers receiving 555 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter Hölig Germany 8 349 191 141 118 76 10 565
J.D. Pipkin United States 16 209 0.6× 175 0.9× 67 0.5× 34 0.3× 39 0.5× 34 529
S. Esmail Tabibi United States 12 213 0.6× 141 0.7× 143 1.0× 64 0.5× 71 0.9× 23 472
Eduardo Jule Denmark 9 473 1.4× 150 0.8× 127 0.9× 137 1.2× 112 1.5× 10 712
Shohei Sugimoto Japan 4 326 0.9× 103 0.5× 114 0.8× 36 0.3× 95 1.3× 7 500
Deepa Patel India 9 271 0.8× 150 0.8× 53 0.4× 55 0.5× 102 1.3× 18 513
Wasfi Al‐Azzam Puerto Rico 14 147 0.4× 343 1.8× 47 0.3× 56 0.5× 96 1.3× 17 580
Pia Skantze Sweden 8 280 0.8× 346 1.8× 137 1.0× 25 0.2× 97 1.3× 8 743
Anja Graf New Zealand 10 285 0.8× 228 1.2× 38 0.3× 35 0.3× 75 1.0× 11 630
Renuka Khatik India 15 158 0.5× 165 0.9× 61 0.4× 37 0.3× 184 2.4× 23 547
Nathaniel D. Catron United States 6 274 0.8× 89 0.5× 165 1.2× 52 0.4× 28 0.4× 7 400

Countries citing papers authored by Peter Hölig

Since Specialization
Citations

This map shows the geographic impact of Peter Hölig's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hölig with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hölig more than expected).

Fields of papers citing papers by Peter Hölig

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter Hölig. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hölig. The network helps show where Peter Hölig may publish in the future.

Co-authorship network of co-authors of Peter Hölig

This figure shows the co-authorship network connecting the top 25 collaborators of Peter Hölig. A scholar is included among the top collaborators of Peter Hölig based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Hölig. Peter Hölig is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Carneiro, Simone Pinto, Francesco Catapano, Ignasi Forné, et al.. (2025). The impact of lipid compositions on siRNA and mRNA lipid nanoparticle performance for pulmonary delivery. European Journal of Pharmaceutical Sciences. 212. 107182–107182. 3 indexed citations
2.
Frank, Kerstin J., Ulrich Westedt, Karin M. Rosenblatt, et al.. (2014). What Is the Mechanism Behind Increased Permeation Rate of a Poorly Soluble Drug from Aqueous Dispersions of an Amorphous Solid Dispersion?. Journal of Pharmaceutical Sciences. 103(6). 1779–1786. 96 indexed citations
3.
Frank, Kerstin J., Karin M. Rosenblatt, Ulrich Westedt, et al.. (2012). Amorphous solid dispersion enhances permeation of poorly soluble ABT-102: True supersaturation vs. apparent solubility enhancement. International Journal of Pharmaceutics. 437(1-2). 288–293. 128 indexed citations
4.
Frank, Kerstin J., Ulrich Westedt, Karin M. Rosenblatt, et al.. (2012). Impact of FaSSIF on the solubility and dissolution-/permeation rate of a poorly water-soluble compound. European Journal of Pharmaceutical Sciences. 47(1). 16–20. 72 indexed citations
5.
Hupfeld, Stefan, Terje Vasskog, Ingunn Tho, et al.. (2010). In situ formation of nanoparticles upon dispersion of melt extrudate formulations in aqueous medium assessed by asymmetrical flow field-flow fractionation. Journal of Pharmaceutical and Biomedical Analysis. 53(3). 359–365. 60 indexed citations
6.
Tho, Ingunn, et al.. (2010). In-vitro permeability screening of melt extrudate formulations containing poorly water-soluble drug compounds using the phospholipid vesicle-based barrier. Journal of Pharmacy and Pharmacology. 62(11). 1591–1598. 44 indexed citations
7.
Hölig, Peter. (2005). Erzeugung und Charakterisierung zielgerichteter liposomaler Trägersysteme für die Tumortherapie. Publikationsserver (Universitat Marburg). 1 indexed citations
8.
Hölig, Peter, et al.. (2004). Targeting of immunoliposomes to endothelial cells using a single-chain Fv fragment directed against human endoglin (CD105). Biochimica et Biophysica Acta (BBA) - Biomembranes. 1663(1-2). 158–166. 49 indexed citations
9.
Hölig, Peter, et al.. (2004). Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells. Protein Engineering Design and Selection. 17(5). 433–441. 97 indexed citations
10.
Bach, Michael, Peter Hölig, E. Schlösser, et al.. (2003). Isolation from phage display libraries of lysine-deficient human epidermal growth factor variants for directional conjugation as targeting ligands. Protein Engineering Design and Selection. 16(12). 1107–1113. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026